AKI is a major public health concern, with significant morbidity and mortality rates. The condition is often reversible if detected and treated early, yet many individuals, especially in resource-limited settings, die due to lack of timely interventions. The 0by25 initiative aims to address these disparities, reduce the global burden of AKI, and improve health outcomes.
